The successful use of low-dose recombinant tissue plasminogen activator for treatment of intracardiac/pulmonary thrombosis during liver transplantation.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 21127275.
- Also identified by DOI 10.1213/ANE.0b013e31820472d4.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Intracardiac thrombosis and pulmonary embolism are uncommon complications during liver transplantation but carry a high mortality rate. We report the successful use of low-dose recombinant tissue plasminogen activator (0.5-4 mg) administration in 4 patients. Early diagnosis through transesophageal echocardiography and pulmonary artery catheterization may have contributed to the rapid thrombolysis.
Medical subject headings
- Fibrinolytic Agents
- Heart Diseases
- Liver Transplantation
- Lung Diseases
- Thrombolytic Therapy
- Thrombosis
- Tissue Plasminogen Activator